Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34765
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAkşit, Dilek-
dc.contributor.authorGökbulut, C.-
dc.date.accessioned2023-11-02T12:34:07Z-
dc.date.available2023-11-02T12:34:07Z-
dc.date.issued2018-01-05-
dc.identifier.citationÇırak, V. Y. vd. (2018). ''Plasma dispositions and concentrations of ivermectin in eggs following treatment of laying hens''. New Zealand Veterinary Journal, 66(3), 121-125.en_US
dc.identifier.issn0048-0169-
dc.identifier.issn1176-0710-
dc.identifier.urihttps://doi.org/10.1080/00480169.2018.1426504-
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/00480169.2018.1426504-
dc.identifier.urihttp://hdl.handle.net/11452/34765-
dc.description.abstractAIMS: To determine the plasma disposition and concentrations of ivermectin (IVM) in eggs produced by laying hens following S/C, oral and I/V administration.METHODS: Twenty-four laying hens, aged 37 weeks and weighing 1.73 (SD 0.12) kg were allocated to three groups of eight birds. The injectable formulation of IVM was administered either orally, S/C, or I/V, at a dose of 0.2mg/kg liveweight, following dilution (1:5, v/v) with propylene glycol. Heparinised blood samples were collected at various times between 0.25 hours and 20 days after drug administration. Eggs produced by hens were also collected daily throughout the study period. Samples of plasma and homogenised egg were analysed using HPLC.RESULTS: Maximum concentrations of IVM in plasma and mean residence time of IVM were lower after oral (10.2 (SD 7.2) ng/mL and 0.38 (SD 0.14) days, respectively) than after S/C (82.9 (SD 12.4) ng/mL and 1.05 (SD 0.24) days, respectively) administration (p<0.01). The time to maximum concentration and elimination half-life were shorter following oral (0.14 (SD 0.04) and 0.23 (SD 0.11) days, respectively) than S/C (0.25 (SD 0.00) and 1.45 (SD 0.45) days, respectively) administration (p<0.01). IVM was first detected in eggs 2 days after treatment in all groups and was detected until 8 days after oral and I/V administration, and until 15 days after S/C administration. Peak concentrations of IVM were 15.7, 23.3 and 1.9 mu g/kg, observed 2, 5 and 4 days after I/V, S/C and oral administration, respectively.CONCLUSIONS AND CLINICAL RELEVANCE: The low plasma bioavailability of IVM observed after oral administration in laying hens could result in lower efficacy or subtherapeutic plasma concentrations, which may promote the development of parasitic drug resistance. Due to high IVM residues in eggs compared to the maximum residue limits for other food-producing animal species, a withdrawal period should be necessary for eggs after IVM treatment in laying hens.en_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectVeterinary sciencesen_US
dc.subjectLaying hensen_US
dc.subjectPoultryen_US
dc.subjectEndectocidesen_US
dc.subjectAnthelminticen_US
dc.subjectIvermectinen_US
dc.subjectPharmacokineticsen_US
dc.subjectEggen_US
dc.subjectResidueen_US
dc.subjectTransit-timeen_US
dc.subjectPharmacokineticsen_US
dc.subject.meshAdministration, oralen_US
dc.subject.meshAnimalsen_US
dc.subject.meshArea under curveen_US
dc.subject.meshBiological availabilityen_US
dc.subject.meshChickensen_US
dc.subject.meshChromatography, high pressure liquiden_US
dc.subject.meshDose-response relationship, drugen_US
dc.subject.meshEggsen_US
dc.subject.meshFemaleen_US
dc.subject.meshInjections, intravenousen_US
dc.subject.meshIvermectinen_US
dc.titlePlasma dispositions and concentrations of ivermectin in eggs following treatment of laying hensen_US
dc.typeArticleen_US
dc.identifier.wos000428158800002tr_TR
dc.identifier.scopus2-s2.0-85041529645tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Veteriner Fakültesi/Parazitoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Veteriner Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-1544-6438tr_TR
dc.identifier.startpage121tr_TR
dc.identifier.endpage125tr_TR
dc.identifier.volume66tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalNew Zealand Veterinary Journalen_US
dc.contributor.buuauthorÇırak, Veli Yılgör-
dc.contributor.buuauthorCihan, Hüseyin-
dc.contributor.researcheridABH-3742-2020tr_TR
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed29378154tr_TR
dc.subject.wosVeterinary sciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ2en_US
dc.contributor.scopusid6602404057tr_TR
dc.contributor.scopusid6602381681tr_TR
dc.subject.scopusEprinomectin; Ivermectin; Abamectinen_US
dc.subject.emtreeIvermectinen_US
dc.subject.emtreeAnalysisen_US
dc.subject.emtreeAnimalen_US
dc.subject.emtreeArea under the curveen_US
dc.subject.emtreeBioavailabilityen_US
dc.subject.emtreeChickenen_US
dc.subject.emtreeDose responseen_US
dc.subject.emtreeEggen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHigh performance liquid chromatographyen_US
dc.subject.emtreeIntravenous drug administrationen_US
dc.subject.emtreeMetabolismen_US
dc.subject.emtreeOral drug administrationen_US
dc.subject.emtreeVeterinaryen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.